Pharmaceutical News

RSS

Flu vaccines have protective effect against heart disease

Flu vaccines are known to have a protective effect against heart disease, reducing the risk of a heart attack. For the first time, this research, published in Vaccine, reveals the molecular mechanism that underpins this phenomenon. The scientists behind the study say it could be harnessed to prevent heart disease directly.

21 Oct 2014

Buprenorphine maintenance therapy better than detoxification for treating prescription opioid dependence

For treating patients with prescription opioid dependence in primary care, buprenorphine maintenance therapy is superior to detoxification, according to a new study by Yale School of Medicine researchers published in the Oct. 20 issue of JAMA Internal Medicine.

21 Oct 2014

Obeticholic acid drug shows promise against bile acid diarrhoea

A pilot study testing a new type of drug in patients with chronic diarrhoea has shown promising effects on reducing their symptoms.

21 Oct 2014

CPS students and staff received EAIs for acute allergic reactions

During the 2012-2013 school year, 38 Chicago Public School (CPS) students and staff were given emergency medication for potentially life-threatening allergic reactions.

21 Oct 2014

Identifying infections rapidly: an interview with Dr. David J. Ecker

Current methods for diagnosing infectious diseases are based on the 150-year-old culture method, where physicians collect a sample of a patient’s tissue, such as blood, mucus or urine, and transfer it onto media bottle to allow the pathogens to grow.

From Abbott Diagnostics 20 Oct 2014

reprintsWarehouse.com: A responsive platform launched by Springer Healthcare for pharmaceutical professionals

Springer Healthcare is proud to announce the launch of reprintsWarehouse.com – a responsive platform that enables pharmaceutical professionals to rapidly identify content that supports their product or device marketing activities, from a database of over 50,000 clinically relevant medical journals, books, continuing medical education materials and anatomical charts.

20 Oct 2014

Aspirin can improve efficacy of schizophrenia treatments

A new study shows that some anti-inflammatory medicines, such as aspirin, estrogen, and Fluimucil, can improve the efficacy of existing schizophrenia treatments. This work is being presented at the European College of Neuropsychopharmacology conference in Berlin.

20 Oct 2014

AmeriCann announces $9M alliance with medical marijuana applicants in Illinois

AmeriCann, Inc., a company that develops cannabis cultivation facilities and provides capital for cannabis entrepreneurs, has partnered with local medical marijuana applicants in the state of Illinois.

20 Oct 2014

Janssen announces submission of IMBRUVICA sNDA to FDA for WM treatment

Janssen Research & Development, LLC today announced the submission of a supplemental New Drug Application (sNDA) for IMBRUVICA (ibrutinib) to the U.S. Food and Drug Administration by its strategic partner Pharmacyclics, Inc.

20 Oct 2014

New drug naming system to be presented at ECNP conference in Berlin

What's in a name? Doctors have found that the name of the drug you are prescribed significantly influences how the patient sees the treatment.

20 Oct 2014

Excess consumption of common pain relievers poses significant health risks to Australians

On the final day of Be Medicinewise Week 2014, NPS MedicineWise is reminding people that excess consumption of common pain relievers is a serious medicine safety issue.

20 Oct 2014

Scientists develop promising vaccination strategy to counteract RSV infection

Respiratory Syncytial Virus causes severe respiratory tract infections and worldwide claims the lives of 160,000 children each year. Scientists at VIB and Ghent University have succeeded in developing a promising vaccination strategy to counteract this common virus infection.

17 Oct 2014

Socioeconomic disadvantages linked to drug-related mortality

For the first time, researchers have found that problem drug users with less successful educational and employment careers are more likely to die of an overdose. Moreover, there is no link between parents' professional status and the likelihood that their problem drug-using child will die from an overdose.

17 Oct 2014

ORNL's Urban Dynamics Institute supports polio vaccination efforts in developing countries

The new Urban Dynamics Institute at the Department of Energy's Oak Ridge National Laboratory is working with the Bill & Melinda Gates Foundation to aid polio vaccination efforts in developing countries.

17 Oct 2014

NIAID announces license agreement to develop dual-purpose candidate vaccines for rabies, Ebola

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced a new license agreement aimed at advancing dual-purpose candidate vaccines to protect against rabies and Ebola viruses.

17 Oct 2014

Myths, misconceptions about seasonal flu and flu vaccine

It's that time of year again. As days shorten, evenings become chilly and the trees start a showy display of color, it's time to roll up your sleeve and get your annual flu vaccine.

16 Oct 2014

Kalorama Information: Experimental vaccine distribution in the UK points to growing flu vaccine market

Kalorama Information believes an experimental vaccine distribution in the United Kingdom and other similar developments point to a growing flu vaccine market, as well as a growing market for the production of these vaccines.

16 Oct 2014

Foreign-born residents with low vaccination rates face greater risk of exposure to diseases

Foreign-born residents with low vaccination rates and their relatives in the U.S. are at greater risk of exposure to several vaccine-preventable diseases, e.g. influenza; pneumococcal diseases; tetanus, diphtheria and pertussis; hepatitis A; hepatitis B; shingles; and HPV, the human papilloma virus, which can lead to some types of cancer.

16 Oct 2014

Actavis seeks FDA approval to market generic version of Quillivant XR

Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.

16 Oct 2014

Epidural and spinal anesthesia safe for relieving pain during childbirth

Women seeking pain relief during childbirth should be comforted to know that epidural and spinal anesthesia are extremely safe, suggests a study of more than 80,000 women that reviewed anesthesia complications during obstetrical care.

16 Oct 2014

Pharmaceutical News

Flu vaccines have protective effect against heart disease

Buprenorphine maintenance therapy better than detoxification for treating prescription opioid dependence

Obeticholic acid drug shows promise against bile acid diarrhoea

CPS students and staff received EAIs for acute allergic reactions

Identifying infections rapidly: an interview with Dr. David J. Ecker

reprintsWarehouse.com: A responsive platform launched by Springer Healthcare for pharmaceutical professionals

Aspirin can improve efficacy of schizophrenia treatments

AmeriCann announces $9M alliance with medical marijuana applicants in Illinois

Janssen announces submission of IMBRUVICA sNDA to FDA for WM treatment

New drug naming system to be presented at ECNP conference in Berlin

Excess consumption of common pain relievers poses significant health risks to Australians

Scientists develop promising vaccination strategy to counteract RSV infection

Socioeconomic disadvantages linked to drug-related mortality

ORNL's Urban Dynamics Institute supports polio vaccination efforts in developing countries

NIAID announces license agreement to develop dual-purpose candidate vaccines for rabies, Ebola

Myths, misconceptions about seasonal flu and flu vaccine

Kalorama Information: Experimental vaccine distribution in the UK points to growing flu vaccine market

Foreign-born residents with low vaccination rates face greater risk of exposure to diseases

Actavis seeks FDA approval to market generic version of Quillivant XR

Epidural and spinal anesthesia safe for relieving pain during childbirth

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News